Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROSE Registry

Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROSE Registry

Abstract Introduction Atopic dermatitis (AD) is a chronic, relapsing disease that can start at any age and has a significant negative impact on quality of life, including a significant itch burden. Here we report the proportion of patients in a real-world study achieving a complete/almost complete r...

Full description

Saved in:
Bibliographic Details
Main Authors: Neal Bhatia, Charles W. Lynde, Luz Fonacier, Liyang Shao, Kwinten Bosman, Andrew Korotzer
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-04-01
Series:Dermatology and Therapy
Subjects:
Atopic dermatitis
Disease control
Dupilumab
Efficacy
Patient-reported outcomes
Real-world study
Online Access:https://doi.org/10.1007/s13555-025-01395-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s13555-025-01395-1

Similar Items